8th International Congress on Cancer Metastasis
L

The Genomic Evolution of Breast Cancer Metastasis: Metastases Mostly Disseminate Late from Primary Breast Tumors, Keeping Most Drivers

By 8th International Congress on Cancer Metastasis FEATURING Lucy Yates
January 17, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
27:39
Breast Health Global Initiative

Metastatic Breast Disease: Treatment and Palliative Care

Feat. A. Eniu
14:37
Cleveland Clinic Taussig Cancer Institute

Hormone Receptor-Postive Advanced Breast Cancer Case 2: Patient with…

Feat. J. Abraham
30:13
Nico Karssemeijer

Deep Learning Systems for Reading Mammograms and Breast Tomosynthesis

19:43
Northwestern Medicine: Chicago Live

Northwestern Live: Live Case - 47 y/o Female with History of Metasta…

Feat. D. Mullady, A. Aadam
19:23
Holy Cross 9th Annual Winter Oncology Symposium

Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhib…

Feat. D. Guaqueta
13:07
Holy Cross 9th Annual Winter Oncology Symposium

Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…

Feat. E. Segota, R. L. Mahtani, J. Burgers, M. Abu-Khalaf, B. Moy
07:43
Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Feat. S. Goel
24:33
Holy Cross 9th Annual Winter Oncology Symposium

Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…

Feat. B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium

Future Directions in the Targeting of HER2+ Breast Cancer: duration …

Feat. B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…

Feat. M. Abu-Khalaf
07:58
Sandra Swain

ASCO 2019 End-of-study Survival Analysis from the Cleopatra Study Sh…

19:29
2019 Scripps MD Anderson's Oncology Update

ASCO Metastatic HER2+ Breast Review: How Long to Treat Is up To Deba…

Feat. J. Mortimer
18:38
Peter Schmid

Immunotherapy in Metastatic Triple Negative Breast Cancer: IMpassion…

07:23
Dana-Farber Cancer Institute

Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer

Feat. S. Tolaney
07:40
Dana-Farber Cancer Institute

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Br…

Feat. S. Tolaney
13:18
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Case of a 65 y/o Woman with DCIS Breast Cancer, pN1 Micrometastases …

Feat. S. Modi, H. Jacene, F. Vicini, H. Rugo
14:20
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Case of a 35 y/o Woman with Micrometastatic Carcinoma, RCB-II Whose …

Feat. S. Modi, H. Jacene, F. Vicini, H. Rugo
05:52
Ashley Mathews

PD-L1 Testing in Breast Cancer: What Makes a Breast Cancer Patient E…

14:11
UNC Lineberger Comprehensive Cancer Center

UNC's 2019 ASCO Update on Margetuximab + Chemo vs Trastuzumab v…

Feat. E. Ray
16:31
Sandra Swain

Firstline Treatment for HER2+ Metastatic Breast Cancer: How HER2-Tar…